PEANUT ALLERGIES
Clinical trials for PEANUT ALLERGIES explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGIES trials appear
Sign up with your email to follow new studies for PEANUT ALLERGIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody aims to neutralize allergies by clearing IgE
Disease control Recruiting nowThis early-stage trial tests an experimental antibody drug called LCA-0061, designed to target and remove immunoglobulin E (IgE), a key driver of allergic reactions. The study first evaluates safety and tolerability in healthy people with elevated IgE levels, then in people with …
Matched conditions: PEANUT ALLERGIES
Phase: PHASE1 • Sponsor: Lycia Therapeutics, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New shot aims to stop peanut allergy emergencies
Disease control Recruiting nowThis early-stage trial tests a drug called MY006, given as a shot under the skin, to see if it can prevent severe allergic reactions from accidental peanut intake. The study involves 48 healthy volunteers and people with peanut allergies, who will receive either the drug or a pla…
Matched conditions: PEANUT ALLERGIES
Phase: PHASE1 • Sponsor: Mabylon AG • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Food allergy treatment: how do kids fare years later?
Knowledge-focused Recruiting nowThis study looks at children and young people who completed an 18-month oral immunotherapy (OIT) treatment for peanut, egg, or milk allergy 5 to 15 years ago. Researchers want to compare quality of life between those whose allergies went into remission and those whose did not. Pa…
Matched conditions: PEANUT ALLERGIES
Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC